ALB|Analyst Targets
ALB|Company Info
ALB|Insider Trading
ALB|Fundamentals
ALB|Earnings Snapshot
EPS
| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q3'26 | $2.58 | - | - |
| Q2'26 | $3.27 | $3.75 | +14.7% |
| Q1'26 | $1.31 | $2.95 | +124.6% |
| Q4'25 | $0.10 | $-0.53 | -621.0% |
| Q3'25 | $-0.88 | $-0.19 | +78.3% |
| Q2'25 | $-0.81 | $0.11 | +113.5% |
Revenue
| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q3'26 | $1.5B | - | - |
| Q2'26 | $1.6B | $1.7B | +7.7% |
| Q1'26 | $1.3B | $1.4B | +8.5% |
| Q4'25 | $1.4B | $1.4B | +5.7% |
| Q3'25 | - | $1.3B | - |
| Q2'25 | - | $1.3B | - |
ALB|Monthly Returns
Market Data
ALB Stock Snapshot
- Market cap
- 11.73B
- P/E ratio
- 52.3
- Day range
- $98.50 – $101.61
- News sentiment
- 64/100 · Bullish
- Analyst target
- $164.73 (+66.4%)
- Consensus
- Buy · 29 analysts
The signal on ALB is bullish: price action is confirming the underlying trend, not fighting it. Institutional coverage is thorough here, so shifts in analyst expectations show up in price quickly.
Behaviour On Record
What ALB's own history says about today's numbers
- Realized volatility (21d)
- 41.3% 56th pct
- Below its peak
- -69.0%
- vs 200-day average
- -34.8%
- Up days (1y)
- 49%
Albemarle Corporation is currently running 41.3% annualised volatility over the last 21 sessions. Measured against ALB's own 13 years of daily returns rather than a market-wide average, that is the 56th percentile — close to its own typical level, against a typical reading of 38.9%. The distinction matters because a number that looks calm for one stock is turbulent for another, and the absolute figure on its own tells you neither.
ALB is trading -69.0% below its running peak. Across 12 full years on file, its median worst-drawdown-in-a-year was -35.4%, and the deepest was -60.4% in 2023. The current drawdown is already deeper than this stock's typical annual low point, which puts it in the part of its range where past recoveries began — and where past declines also continued.
Price sits -34.8% from its 200-day moving average. Against every other day in its history, that gap ranks at the 2nd percentile — a narrower gap than it typically runs. Over the past year ALB closed higher on 49% of sessions, and it is currently 1 session into a rising streak.
On October specifically: over 14 years of records, ALB finished the month higher 9 of 14 times, with a median return of +1.6% and an average of +1.9%. Its strongest month historically has been November at +6.9% on average, its weakest March at -3.2%. Seasonality is a weak signal on its own — a decade is a small sample and regimes change — but it is a real distribution rather than a rule of thumb.
Overnight risk is measurable too: ALB has opened more than 2% away from the prior close in 232 of 3,266 sessions (7.1% of the time), with the largest gaps running +9.3% and -21.8%. For anyone holding through an event, that rate is a better guide to overnight exposure than the intraday range.
Across the last 3 dated reports on file, ALB moved an average of 3.8% in the session after earnings, closing higher 1 of those 3 times, with a median move of -0.5% and a largest of -6.1%.
All figures computed from 3,267 daily closes between 2013-10-15 and 2026-10-14, split-adjusted, recomputed daily. Percentiles are against ALB's own 13-year history, not a peer group or index.
Sector Rotation
Is money rotating into or out of ALB's sector?
Albemarle Corporation sits in the Materials sector, currently ranked 10th of 12 GICS sectors by relative-strength rotation score (improving).
- Sector rank
- #10 of 12
- Sector state
- Improving
- Sector rotation score
- 9
Analyst Rating Changes
Are analysts turning bullish or bearish on ALB?
Barclays most recently initiated coverage on Albemarle Corporation to Equal-Weight on Oct 13, 2026 with a price target of $109. Over the last 90 days, coverage has run 0 upgrades against 0 downgrades, a net mixed lean.
- Latest action
- Barclays — Equal-Weight
- 90-day upgrades
- 0
- 90-day downgrades
- 0
- Net rating momentum
- 0
Earnings Release, Scored
What did Albemarle Corporation's latest earnings release say?
Most important lines
- 1
Increasing full-year Specialties net sales outlook to $1.4 to $1.6 billion and adjusted EBITDA outlook to $275 to $325 million, due to stronger-than-expected pricing and volume performance year to date.
Guidance raisedNew this quarter - 2
Reducing full-year capital expenditure forecast to approximately $500 million due to ongoing capital efficiency improvements.
Guidance loweredNew this quarter - 3
Albemarle expects its full-year 2026 capital expenditures to be approximately $500 million, down 15% compared to 2025 due to ongoing capital efficiency improvements.
Guidance loweredNew this quarterNegative tone
Peers & ETF holders
ALB peers & ETF holders
Specialty ChemicalsMarket cap · today
News Sentiment Analysis
Sentiment gathered from recent headlines
Recent News Coverage
Most recent articles, ranked by recency (click to expand).
Technical Analysis
Real-time indicators across multiple timeframes
| Manager | Trend | Shares Held | % of Co. | Position Value | Filed |
|---|---|---|---|---|---|
| Vanguard Group Inc | ▼ Sell | 14,529,573 | 12.45% | $2.06B | 2026-01-29 |
| Capital World Investors | ▲ Buy | 9,901,852 | 8.49% | $1.34B | 2026-08-12 |
| BlackRock, Inc. | ▲ Buy | 9,501,587 | 8.14% | $1.28B | 2026-08-07 |
| Geode Capital Management, LLC | ▼ Sell | 3,129,997 | 2.68% | $421.87M | 2026-08-12 |
| Morgan Stanley | ▲ Buy | 2,895,892 | 2.48% | $391.03M | 2026-08-13 |
| FMR LLC (Fidelity) | ▲ Buy | 2,685,901 | 2.30% | $362.68M | 2026-08-13 |
| Bank of America Corp | ▼ Sell | 2,543,325 | 2.18% | $343.43M | 2026-08-14 |
| Invesco Ltd. | ▲ Buy | 1,853,020 | 1.59% | $250.21M | 2026-08-14 |
| Goldman Sachs Group Inc | ▼ Sell | 1,663,086 | 1.43% | $224.57M | 2026-08-14 |
| JPMorgan Chase & Co | ▼ Sell | 1,576,429 | 1.35% | $205.20M | 2026-08-12 |
| Two Sigma Investments, LP | ▼ Sell | 1,460,730 | 1.25% | $197.24M | 2026-08-14 |
| Norges Bank | ▲ Buy | 1,394,324 | 1.19% | $188.28M | 2026-08-12 |
| Northern Trust Corp | ▼ Sell | 1,218,132 | 1.04% | $164.48M | 2026-08-13 |
| AQR Capital Management LLC | ▼ Sell | 1,155,790 | 0.99% | $154.62M | 2026-08-14 |
| Citadel Advisors LLC | ▲ Buy | 875,071 | 0.75% | $118.16M | 2026-09-02 |
| Sculptor Capital LP | ▲ Buy | 1,668,727 | 1.43% | $92.49M | 2026-08-14 |
| AllianceBernstein L.P. | ▼ Sell | 432,305 | 0.37% | $77.61M | 2026-08-14 |
| Renaissance Technologies LLC | ▼ Sell | 456,145 | 0.39% | $61.59M | 2026-08-13 |
| Wells Fargo & Company | ▼ Sell | 344,822 | 0.30% | $46.56M | 2026-08-14 |
| Citigroup Inc | ▼ Sell | 311,735 | 0.27% | $42.09M | 2026-08-03 |
| Susquehanna International Group, LLP | ▲ Buy | 301,579 | 0.26% | $40.72M | 2026-08-14 |
| Baillie Gifford & Co | ▼ Sell | 296,531 | 0.25% | $40.04M | 2026-08-06 |
| Man Group plc | ▲ Buy | 238,669 | 0.20% | $32.23M | 2026-08-14 |
| Gotham Asset Management, LLC | ▲ Buy | 211,504 | 0.18% | $28.56M | 2026-08-14 |
| Janus Henderson Group plc | ▼ Sell | 117,125 | 0.10% | $21.03M | 2026-05-18 |
| Member | Chamber | State | Type | Amount | Traded | Filed |
|---|---|---|---|---|---|---|
| John Boozman | Senate | AR | ▲ Buy | $1K - $15K | 2026-05-15 | 2026-06-16 |
| Jefferson Shreve | House | IN06 | ▼ Sell | $15K - $50K | 2025-05-12 | 2025-06-22 |
| Jefferson Shreve | House | IN06 | ▲ Buy | $15K - $50K | 2025-04-07 | 2025-05-08 |
| Jefferson Shreve | House | IN06 | ▼ Sell | $15K - $50K | 2025-02-24 | 2025-03-09 |
| Julie Johnson | House | TX32 | ▼ Sell | $1K - $15K | 2025-02-12 | 2025-03-12 |